Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group StudyAli AYHANa, İrfan ÇİÇİNb, Ali GÖKYERb, Mustafa Erkan SARIc, Ahmet Taner TURANd, Salih TAŞKINe, Kemal GÜNGÖRDÜKf, Özgür AKBAYIRg, Pınar SAİPh, Hanifi ŞAHİNc, Gonca ÇOBANa, Samet TOPUZi, İlker SELÇUKc, Gökhan TULUNAYg, Mehmet Mutlu MEYDANLIcaBaşkent University Faculty of Medicine, Division of Gynecologic Oncology, Ankara, TURKEY
bTrakya University Faculty of Medicine, Department of Medical Oncology, Edirne, TURKEY
cUniversity of Health Sciences, Zekai Tahir Burak Women’s Health Training and Research Hospital, Department of Gynecologic Oncology, Ankara, TURKEY
dUniversity of Health Sciences, Etlik Zübeyde Hanim Women’s Health Training and Research Hospital, Department of Gynecologic Oncology, Ankara, TURKEY
eAnkara University Faculty of Medicine, Division of Gynecologic Oncology, Ankara, TURKEY
fUniversity of Health Sciences Tepecik Education and Research Hospital, Department of Gynecologic Oncology, İzmir, TURKEY
gUniversity of Health Sciences Kanuni Sultan Süleyman Training and Research Hospital, Department of Gynecologic Oncology, İstanbul, TURKEY
hİstanbul University İstanbul Faculty of Medicine, Department of Medical Oncology, İstanbul, TURKEY
iIstanbul University İstanbul Faculty of Medicine, Division of Gynecologic Oncology, İstanbul, TURKEYDOI: 10.37047/jos.2019-73073 Sayfalar: 78 - 86 2122 Viewed.
JOURNAL of
EN